Tag Archives: diabetes

Surge in support for chronic disease action

Research released this week shows a significant increase in public support for government action on chronic disease. The 2018 Australian Perceptions of Prevention Survey (AUSPOPS) found more than 60 per cent of respondents supported a large role for government in maintaining people’s health, up from 46 per cent in 2016. …

Read More »

AF leading cause of CV hospitalisation

Atrial fibrillation (AF), the irregular, rapid heart rate that can cause heart palpitations, fatigue, shortness of breath and death, has overtaken heart failure and heart attacks as the leading cause of cardiovascular (CV) hospitalisation, a South Australian study has found. Researchers analysed data collected over two decades by the Australian …

Read More »

Gold for a top Guild pharmacy

The Pharmacy Guild has congratulated healthSAVE Wilkinson’s Pharmacy on winning the 2019 Guild Award for Excellence in Community Engagement – Health Services. In the Tasmanian coastal town of Burnie, healthSAVE Wilkinson’s Pharmacy has operated at the same site for more than 35 years. The Guild says it continues to serve …

Read More »

A finer point

A new ultra-fine 5mm pen needle with five-bevel comfort has been introduced by BD Becton Dickinson) for injecting insulin in Australia. BD says an extra thin wall, or cannula, improves the flow rate of insulin for a faster injection, and the design of a new needle tip reduces penetration force …

Read More »

Human intervention in diabetes

Switching patients with type 2 diabetes from insulin analogues to human insulin could save a lot of money without causing harm, new research suggests. Findings were recently published from a US study of 14,635 participants who filled a total of 221,866 insulin prescriptions in 2014-2016. The US study examined differences …

Read More »

PBS lists new diabetes drug

A new treatment option is available for adult patients with Type 2 Diabetes. Steglatro (ertugliflozin), listed on the Pharmaceutical Benefits Scheme, is a new, SGLT2 inhibitor treatment option for Type 2 Diabetes Mellitus (T2DM). Steglatro provides healthcare care professionals with another option for patients that are currently on metformin +/- …

Read More »